|
Adverse Effects
Citations 21-30 of 96 total displayed.
|
Past content
(since May 1999):
|
- Observations
Glatiramer Acetate–Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
- Monica M. Madray; John F. Greene Jr; David F. Butler
Arch Neurol 2008; 65: 1378-1379.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Anticoagulation After Cardioembolic Stroke: To Bridge or Not to Bridge?
- Hen Hallevi; Karen C. Albright; Sheryl Martin-Schild; Andrew D. Barreto; Sean I. Savitz; Miguel A. Escobar; Nicole R. Gonzales; Elizabeth A. Noser; Kachi Illoh; James C. Grotta
Arch Neurol 2008; 65: 1169-1173.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Anticoagulation After Cardioembolic Stroke: To Bridge or Not to Bridge?
- Hen Hallevi; Karen C. Albright; Sheryl Martin-Schild; Andrew D. Barreto; Sean I. Savitz; Miguel A. Escobar; Nicole R. Gonzales; Elizabeth A. Noser; Kachi Illoh; James C. Grotta
Arch Neurol 65.9.noc70105.
[Abstract]
[Full text]
[]
- Correspondence
Type III Systemic Allergic Reaction to Natalizumab
- Verena I. Leussink; Helmar C. Lehmann; Hans-Peter Hartung; Ralf Gold; Bernd C. Kieseier
Arch Neurol 2008; 65: 851-a-852-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Type III Systemic Allergic Reaction to Natalizumab—Reply
- Markus Krumbholz; Hannah Pellkofer; Ralf Gold; Lisa Ann Hoffmann; Reinhard Hohlfeld; Tania Kümpfel
Arch Neurol 2008; 65: 852-a.
[Extract]
[Full text]
[PDF]
- Editorials
Antiplatelet Therapy and the Risk of Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
- Hen Hallevi; James C. Grotta
Arch Neurol 2008; 65: 575-576.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations: The ADVANS Study
- Olivier Rascol; Werner Poewe; Andrew Lees; Marina Aristin; Laurence Salin; Nolwenn Juhel; Lisa Waldhauser; Thomas Schindler; for the ADVANS Study Group
Arch Neurol 2008; 65: 577-583.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
- Maarten Uyttenboogaart; Marcus W. Koch; Karen Koopman; Patrick C. A. J. Vroomen; Jacques De Keyser; Gert-Jan Luijckx
Arch Neurol 2008; 65: 607-611.
[Abstract]
[Full text]
[PDF]
- Observations
Allergic and Nonallergic Delayed Infusion Reactions During Natalizumab Therapy
- Kerstin Hellwig; Sebastian Schimrigk; Malte Fischer; Aiden Haghikia; Thomas Müller; Andrew Chan; Ralf Gold
Arch Neurol 2008; 65: 656-658.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
- Maarten Uyttenboogaart; Marcus W. Koch; Karen Koopman; Patrick C. A. J. Vroomen; Jacques De Keyser; Gert-Jan Luijckx
Arch Neurol 65.5.noc70077.
[Abstract]
[Full text]
[]
|
|
